Citadel Advisors - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$42,745
-34.5%
16,568
+9.6%
0.00%
Q2 2023$65,284
-1.8%
15,112
-65.2%
0.00%
Q1 2023$66,454
+2.8%
43,434
+6.2%
0.00%
Q4 2022$64,647
+50.3%
40,916
+17.2%
0.00%
Q3 2022$43,000
+19.4%
34,912
+93.8%
0.00%
Q2 2022$36,000
-75.2%
18,012
-68.9%
0.00%
Q1 2022$145,000
-66.4%
57,832
-50.1%
0.00%
Q4 2021$432,000
+2.1%
115,800
+9.9%
0.00%
Q3 2021$423,000
+52.2%
105,354
+68.8%
0.00%
Q2 2021$278,000
+47.1%
62,398
+202.9%
0.00%
Q1 2021$189,00020,6010.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders